Carta Genum
PrivateLast Round
Pre Seed
Jan 1, 2026
Total Funding Raised
$50,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Carta Genum is a biotechnology company that provides an end-to-end analytical infrastructure to translate raw spatial biology data into publication-ready results.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Healthcare Analytics, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Carta Genum Comparables
Compare Carta Genum with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Enable Medicine | 77% | |
| BioTuring | 64% | |
| Stellaromics | 60% |
Carta Genum Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Jan 1, 2026 |
Carta Genum Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Czech Founders VC | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2026
$50K round led by Czech Founders VC
Carta Genum Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Carta Genum's valuation, stock price, and market status.
Is Carta Genum a public or private company?
Carta Genum is a private company.
What is the current stock price of Carta Genum?
Carta Genum is a private company, so its shares have no public market price. Caplight tracks Carta Genum's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Carta Genum worth (valuation)?
Valuation information for Carta Genum is not publicly available.
Can I buy Carta Genum stock?
Carta Genum shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Carta Genum's last funding round?
Carta Genum's most recent funding round was Pre Seed on January 1, 2026.
Who are the main investors in Carta Genum?
Key investors in Carta Genum include Czech Founders VC.
Will Carta Genum IPO soon?
No public IPO plans have been announced for Carta Genum.
How can I track Carta Genum secondary market activity?
Caplight tracks bids, offers, and trades in Carta Genum's shares on secondary markets.